Clinical role of serum microRNA-155 in early diagnosis and prognosis of septic patients with acute kidney injury
ConclusionSerum miR-155 can be used as a novel biomarker for the early diagnosis of septic AKI, and also has important clinical value in the prognosis evaluation of septic patients with AKI.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Urology & Nephrology